AwesomeCapital
Search This Blog
Thursday, April 25, 2019
Bristol-Myers says Phase 2 CheckMate -714 trial did not meet primary endpoints
https://thefly.com/landingPageNews.php?id=2897264
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.